Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice

The functional interactions between the endogenous cannabinoid and opioid systems were evaluated in pre-proenkephalin-deficient mice. Antinociception induced in the tail-immersion test by acute Delta9-tetrahydrocannabinol was reduced in mutant mice, whereas no difference between genotypes was observ...

ver descrição completa

Detalhes bibliográficos
Autores: Valverde Granados, Olga, Maldonado, Rafael, 1961-, Valjent, Emmanuel, Zimmer, Anne M., Zimmer, Andreas
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2000
País:España
Recursos:Universitat Pompeu Fabra
Repositório:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/16670
Acesso em linha:http://hdl.handle.net/10230/16670
http://dx.doi.org/10.1523/jneurosci.20-24-09284.2000
Access Level:Acceso aberto
Palavra-chave:Cannabinoides -- Efectes fisiològics
Cannabinoides -- Receptors
Drogoaddicció -- Aspectes moleculars
Cannabinoid
Opioid
Mice
Mutation
Withdrawal
Addiction
Tolerance
Descrição
Resumo:The functional interactions between the endogenous cannabinoid and opioid systems were evaluated in pre-proenkephalin-deficient mice. Antinociception induced in the tail-immersion test by acute Delta9-tetrahydrocannabinol was reduced in mutant mice, whereas no difference between genotypes was observed in the effects induced on body temperature, locomotion, or ring catalepsy. During a chronic treatment with Delta9-tetrahydrocannabinol, the development of tolerance to the analgesic responses induced by this compound was slower in mice lacking enkephalin. In addition, cannabinoid withdrawal syndrome, precipitated in Delta9-tetrahydrocannabinol-dependent mice by the injection of SR141716A, was significantly attenuated in mutant mice. These results indicate that the endogenous enkephalinergic system is involved in the antinociceptive responses of Delta9-tetrahydrocannabinol and participates in the expression of cannabinoid abstinence.